Collagen induced arthritis in rats. Contrasting effect of subcutaneous versus intradermal inoculation of type II collagen

Journal of Rheumatology

Volumn 25, Issue 10, 1998, Pages 1945-1952

  Bakharevski, Olga ^a,b   Stein Oakley, Alicia N ^a,b   Thomson, Napier M ^a,b   Ryan, Peter F J ^a,b  

^a ALFRED HOSPITAL   (Australia)

^b Department of Medicine ^*

Author keywords

Antibodies; Collagen induced arthritis; Tolerance

Indexed keywords

COLLAGEN TYPE 2; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; FEMALE; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INTRADERMAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ARTHRITIS; BIOLOGICAL MARKERS; COLLAGEN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULINS; INJECTIONS, INTRADERMAL; INJECTIONS, SUBCUTANEOUS; JOINTS; RATS; RATS, INBRED LEW;

EID: 0031752109     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 1977;146:857-68.
2. Carlson RP, Datko LJ, O'Neill-Davis L, et al. Comparison of inflammatory changes in established type II collagen-and adjuvant-induced arthritis using outbred Wistar rats. Int J Immunopharmacol 1985;7:811-26.
3. Horn JT, Stuart JM. Chiller JM. Murine T cells reactive to type II collagen. I. Isolation of lines and clones and characterisation of their antigen-induced proliferative responses. J Immunol 1986;136: 769-75.
4. Kobayashi S, Terato K, Harada Y. Moriya H, Taniguchi M. Suppression of type II collagen-induced arthritis by monoclonal antibodies. Arthritis Rheum 1991;34:48-54.
5. Sugita T, Furukawa O, Ueno M, Murakami T, Takata I, Tosa T. Enhanced expression of interleukin 6 in rat and murine arthritis models. Int J Immunopharmacol 1993;15:469-76.
6. Cremer MA, Hernandez AD, Townes AS. Stuart JM, Kang AH. Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen. J Immunol 1983;131:2995-3000.
7. Thompson HSG, Staines NA. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats. Clin Exp Immunol 1985;64:581-6.
8. Nagler-Anderson C, Bober LA, Robinson ME, Siskind GW, Thorbecke GJ. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci USA 1986;83:7443-6.
9. Staines NA, Kakimoto K. Oral tolerance and collagen arthritis [letter]. Br J Rheumatol 1992;31:283-4.
10. Khare SD, Krco CJ, Griffiths MM, Luthra HS, David CS. Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. J Immunol 1995;155:3653-9.
11. al-Sabbagh A, Nelson PA, Akselband Y, Sobel RA, Weiner HL. Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type 11 collagen. Cell Immunol 1996;171:111-9.
12. Stein-Oakley AN, Maguire JA, Dowling J, Perry G, Thomson NM. Altered expression of fibrogenic growth factors in IgA nephropathy and focal and segmental glomerulonephritis. Kidney Int 1997;51:195-204.
13. Glenn EM, Gray J. Adjuvant-induced polyarthritis in rats: biologic and histologic background. Am J Vet Res 1965;26:1180-94.
14. Stuart JM, Cremer MA, Kang AH, Townes AS. Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum 1979;22:1344-51.
15. Kleinau S, Erlandsson H, Holmdahl R, Klareskog L. Adjuvant oils induce arthritis in the DA rat. I. Characterisation of the disease and evidence for an immunological involvement. J Autoimmun 1991;4:871-80.
16. Cannon GW, Woods ML, Clayton F, Griffiths MM. Induction of arthritis in DA rats by incomplete Freund's adjuvant. J Rheumatol 1993;20:7-11.
17. Kupper TS. Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations [published erratum appears in J Clin Invest 1991 Feb;87(2):753]. J Clin Invest 1990;86:1783-9.
18. Williams IR, Kupper TS. Immunity at the surface: homeostatic mechanisms of the skin immune system. Life Sci 1996;58:1485-507.
19. Witmer-Pack MD, Olivier W, Valinsky J, Schuler G, Steinman RM. Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells. J Exp Med 1987;166:1484-98.
20. Heufler C, Koch F, Schuler G. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med 1988;167:700-5.
21. Markowicz S, Engleman EG. Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro. J Clin Invest 1990; 85:955-61.
22. Kimber I, Cumberbatch M. Stimulation of Langerhans cell migration by tumor necrosis factor alpha (TNF-alpha). J Invest Dermatol 1992;99:48s-50s.
23. de Kossodo S, Cruz PD, Jr., Dougherty I, Thompson P. Silva-Valdez M, Beutler B. Expression of the tumor necrosis factor gene by dermal fibroblasts in response to ultraviolet irradiation or lipopolysaccharide. J Invest Dermatol 1995;104:318-22.
24. Cumberbatch M, Kimber I. Tumour necrosis factor-alpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 1995;84:31-5.
25. Knight SC, Mertin J, Stackpoole A, Clark J. Induction of immune responses in vivo with small numbers of veiled (dendritic) cells. Proc Natl Acad Sci USA 1983;80:6032-5.
26. Knight SC, Chan JF, Bryant A, Bedford PE, Bateman C. Induction of autoimmunity with dendritic cells: studies on thyroiditis in mice. Clin Immunol Immunopathol 1988;48:277-89.
27. Nussenzweig MC, Steinman RM. Contribution of dendritic cells to stimulation of the murine syngeneic mixed leukocyte reaction. J Exp Med 1980;151:1196-212.
28. Inaba K, Steinman R. Resting and sensitised T lymphocytes exhibit distinct stimulatory (antigen presenting cell) requirements tor growth and lymphokine release. J Exp Med 1984;160:1717-35.
29. Vakkila J, Hurme M. Both dendritic cells and monocytes induce autologous and allogeneic T cells receptive to interleukin 2. Scand J Immunol 1990;31:75-83.
30. Jenkins MK, Schwart RH. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vivo. J Exp Med 1987;165:302-19.
31. Quill H, Schwartz RH. Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative unresponsiveness. J Immunol 1987;138:3704-12.
32. Williams ME, Lichtman AH, Abbas AK. Anti-CD3 antibody induces unresponsiveness to IL-2 in Th1 clones but not in Th2 clones. J mmunol 1990;144:1208-14.
33. Sloan-Loncaster J, Evavold BD, Allen PM. Th2 cell clonal anergy as a consequence of partial activation. J Exp Med 1994;180:1195-205.
34. De Becker G, Sornasse T, Nabavi N, et al. Immunoglobulin isotype regulation by antigen-presenting cells in vivo. Eur J Immunol 1994;24:1523-8.
35. Sornasse T, Flamand V, De Becker G. et al. Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. J Exp Med 1992;175:15-21.
36. Thompson HSG, Henderson B, Spenser JM, Hobbs SM, Peppard JV. Staines NA. Tolerogenic activity of polymerized type II collagen in preventing collagen-induced arthritis in rats. Cli Exp Immunol 1988;72:20-5.
37. Wilbanks GA, Streilein JW. Distinctive humoral immune responses following anterior chamber and intravenous administration of soluble antigen. Evidence for active suppression of IgG2-secreting B lymphocytes. Immunology 1990;71.566-72.
38. Staines NA, Harper N, Ward FJ, Malmstrom V, Holmdahl R, Bansal S. Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope. Cli Exp Immunol 1996;103:368-75.
39. Thomas R, Lipsky PE. Presentation of self peptides by dendritic cells: possible implications for the pathogenesis of rheumatoid arthritis. Arthritis Rheum 1996;39:183-90.